Steven King was appointed President of Avid Bioservices in 2001. In his capacity as president of Avid, he was given the responsibility in 2001 to transform Peregrine Pharmaceuticals in-house dedicated manufacturing facility into a multi-product biologics contract manufacturing organization. He has continued serving as President of Avid since its inception and also serves as president and CEO of Peregrine Pharmacteuticals. Steven's background is in research and development of biologics and he is a co-inventor on over 25 U.S. and foreign patents and patent applications. He holds BS and MS degrees in Biology from Texas Tech University.

Paul Lytle has served as Chief Financial Officer since August 2002. Mr. Lytle oversees Finance & Accounting, SEC Reporting, Investor Relations, Human Resources and Information Technology. Mr. Lytle started with Peregrine, the parent company of Avid, in March 1997 as Corporate Controller and has held positions of increasing responsibility at the company. Mr. Lytle has been responsible for the development and implementation of numerous technology initiatives, increasing the company's efficiency in many areas, including finance. During his tenure, Peregrine has raised over $100 million in equity financing from the public markets. Prior to joining Peregrine, Mr. Lytle worked for Deloitte & Touche LLP. Mr. Lytle holds a BS in Business Administration from the California State University at Long Beach and is a certified public accountant in the State of California and a member of the American Institute of Certified Public Accountants.

David King, Vice President of Business Development, has over 20 years of commercial experience in the biopharmaceutical industry, including sales, marketing and extensive business development experience. His expertise in this area has led to the completion of significant corporate partnering deals with industry partners. He has identified, negotiated and closed a wide range of transactions including out-license, in-license, co-promotion and joint development and marketing agreements. Mr. King has an extensive network of contacts at biopharmaceutical companies in North America, Europe and Asia. Mr. King was formerly employed with Medinox, Inc., in San Diego, where he served as Vice President, Corporate Development. Previously, Mr. King held several executive and management level positions at various pharmaceutical companies, including Maxim Pharmaceuticals, DepoTech Corporation (now SkyePharma Ltd.), and Glaxo Inc. (now GlaxoSmithKline). He began his pharmaceutical industry career in sales and marketing for Stuart Pharmaceuticals (now AstraZeneca). Mr. King holds a bachelor's degree in Business Administration from Goshen College in Goshen, IN.

Richard Richieri was appointed VP of manufacturing in October of 2001. Richard has over ten years of experience in the biologics industry manufacturing proteins and antibodies. At Peregrine, as director of manufacturing, Richard was responsible for process development and manufacture of clinical trial materials. At Avid Bioservices, Richard is responsible for all manufacturing including process development and facilities. Prior to joining Peregrine, Richard worked at Xoma Corporation where he was responsible for large-scale manufacturing and mammalian cell culture process development utilizing Xoma's CHO cell line. Richard received his M.S. from University of California, San Diego (UCSD) studying the dependency of antibody production on cell cycle kinetics. He received his Bachelor's degree from University of California, Los Angeles (UCLA) in Chemical Engineering. Mr. Richieri is licensed as an Exemptee Pharmacist by the Board of Pharmacy State of California.

Teresa Berry is the Director of Facilities at Avid Bioservices. She has over twelve (12) years of experience in the industrial and commercial construction industry. In addition, she has over thirteen (13) years of experience with cGMP Facilities Operations in the biotechnology industry. Ms. Berry holds a Bachelor's degree in Health Sciences from California State University, Long Beach (CSULB). She is a Journeyman Inside Wireman with The International Brotherhood of Electrical Workers and is an active member of The International Society of Pharmaceutical Engineers. Prior to joining Avid Bioservices the Facilities Director worked for XOMA Corporation for nine years at their Santa Monica Pilot Plant in charge of the Facilities Operations. At Avid Bioservices, Ms. Berry is responsible for the preventative maintenance, calibrations, and repairs of all equipment and utilities, maintaining facility grounds and buildings, building construction and planning and the execution of those projects.

Shay Tabani is the Director for Quality Assurance and is also the Quality Management Representative. Shay started with Peregrine Pharmaceuticals, Inc. in May 1997 and she currently coordinates all aspects of the Quality Program, including, developing and administering the program, establishing policies, procedures at all levels to ensure compliance with cGMPs that meet both internal and external customers' requirements, training, and facilitating change throughout the organization. She manages Document Control, Product Review (including review of Batch Production Records and lot disposition), and QA Compliance (including internal and supplier audits). Shay also oversees regulatory inspections such as FDA, EMEA, State of California-Department of Health-Food and Drug Branch, ISO audits, client and regulatory compliance audits. Shay was previously employed at The Hartley Company as a Chemist. Prior to that, she taught Chemistry to High School students. She received her M.S. in Physical Chemistry from the University of Karachi, Pakistan. In March 1999, Shay completed her Certified Quality Manager Preparation course from Irvine Valley College. Shay is a Senior Member of the American Society for Quality.

Gene heads the Manufacturing Department at Avid Bioservices which is responsible for all GMP cell banking, upstream, downstream, and filling processes. Gene has over 10 years of experience working in the biopharmaceutical industry with 8 years focused on GMP manufacturing. Prior to joining Avid Bioservices, Gene has worked at Peregrine Pharmaceuticals as a Research Associate and Manufacturing Manager, Amgen Incorporated as a Materials Associate, and IDEC Pharmaceuticals as a Cell Culture Technician. His hands-on experience with mammalian cell culture, monoclonal antibody purification, and Manufacturing Support Systems were developed while working in Quality Control, Manufacturing, Inventory Control and Process Development groups. Gene earned his B.S. in Biology at the University of California, Irvine in 1996.

John L. Quick has been associated with Peregrine and Avid since mid-2004 as a consultant on quality and regulatory compliance. He is founder of Quick & Associates a consulting firm devoted to quality, regulatory compliance and new product development consulting. Mr. Quick retired from Baxter International after a 37 year career with the company with responsibility for new product development and quality management . In 1998, Mr. Quick was appointed corporate vice president quality/regulatory compliance responsible for all worldwide quality and regulatory compliance at Baxter, reporting to the Chairman and CEO, a position he held until his retirement. Mr. Quick is immediate past Chairman of the Board of the Lincoln Foundation for Performance Excellence and is Vice Chairman of the Board of Methodist Hospital of Chicago and its parent corporation. Mr. Quick has an undergraduate degree in Chemistry from Indiana University and an MBA from the Northwestern J.L. Kellogg Graduate School of Management. He holds three issued patents and has made numerous industry presentations on the subject of quality and regulatory compliance.

Jennifer earned a Bachelor's of Science degree in Biology with a minor in Chemistry from California State University, San Bernardino. Jennifer started with Avid as a research associate and has since moved into a supervisory role. As Supervisor of Analytical Methods Development, she is responsible for all assay transfer and development activities as well as assay qualifications and validations at Avid Bioservices. The Analytical Methods Development department's overall goal is to support clients and other departments within Avid in their pursuit of meeting FDA regulatory requirements as they pertain to analytical testing. Jennifer's experience in transferring assays from a non-regulated environment to a cGMP laboratory, through assay development or optimization as needed, provides a valuable advantage to incoming clients. Additionally, the Analytical Methods Development department supports the Analytical Quality Control, Manufacturing, Research & Development, and Process Development departments by spearheading troubleshooting efforts, performing equipment validations used in testing, and supporting studies by providing testing as needed.